Objectives: Antibiotic susceptibility testing of the Mycobacterium avium complex is often characterized by a lack of correlation between in vitro results and clinical response. The reason for this discrepancy might lie in the difference between in vitro susceptibility testing conditions and the actual environment experienced by mycobacteria in the host. The availability of iron is one such difference, which is limited in host macrophages upon infection, but abundant in susceptibility testing media. Accordingly, the aim of our study was to determine whether iron limitation affects the antibiotic susceptibility profile of M. avium subspecies hominissuis.
Introduction
Mycobacterium avium subspecies hominissuis (MAH) causes serious infections, predominantly in immunocompromised people. 1 The choice of suitable antibiotics for treatment is hindered by the lack of correlation between in vitro susceptibility results and the clinical outcome. 2 Reasons for this might lie in differences between the in vitro and in vivo growth conditions of these organisms. In vivo, MAH replicates within the phagosomes of macrophages, where it has to overcome different host defence strategies in order to survive. 1, 3 One such strategy employed by the host is limiting the availability of iron. 3 Pathogenic mycobacteria respond to this challenge by activating an iron acquisition system, which includes the synthesis of highaffinity iron chelators, mycobactins. 4 However, the full extent of metabolic changes in mycobacteria induced by iron limitation reaches far beyond iron acquisition systems and leads to the development of a distinctive phenotype, 5, 6 which could have significantly different susceptibilities to antibiotics than those determined in vitro. The current media used for the antibiotic susceptibility testing of mycobacteria (Middlebrook 7H series, also used in MGIT tubes, and Lö wenstein -Jensen) are predominantly rich in iron, containing .100 mM iron, while an iron-limitation response in mycobacteria is observed at concentrations of iron ,1 mM.
7 Consequently, the difference in iron availability between in vitro and in vivo conditions could importantly contribute to the low predictive value of in vitro susceptibility testing.
Accordingly, the aim of our study was to determine whether iron limitation affects the antibiotic susceptibility profile of MAH strain 104 (MAH 104) and to characterize the metabolic state of iron-deprived MAH by monitoring differences in the susceptibility to antibiotics targeting various metabolic processes.
Materials and methods

Culture conditioning
In all experiments, MAH 104 8 was used. The culture was maintained on Herrold's egg yolk slants (Becton Dickinson, USA). Cultures were preconditioned in Sauton's medium (per L: 0.5 g of KH 2 PO 4 , 0.5 g of MgSO 4 .7H 2 O, 2.0 g of citric acid, 60 mL of glycerol, 4.0 g of L-asparagine, 1 mg of ZnSO 4 .7H 2 O and 250 mg of Tween 80, pH 6.8). Such preconditioned cultures were further conditioned with respect to the iron concentration by repeated subcultivation in the same fresh medium, but with added iron (S+Fe, [Fe] ¼ 100 mM, as FeCl 3 ) or without added iron (S2 Fe, [Fe] , 0.5 mM), to simulate normal-iron (corresponding to iron concentrations normally present in media for antibiotic susceptibility testing of mycobacteria) or low-iron conditions, respectively. Iron concentrations of ,0.5 mM were previously confirmed to induce an iron-deficiency response in mycobacteria. 7 Iron concentrations in all cultures were determined with a modified ferrozine assay. 9 Preparation of bacterial suspensions for antibiotic susceptibility testing Three bacterial suspensions were prepared for every antibiotic susceptibility experiment. At the mid-exponential phase, 20 mL of S+Fe-and S2Fe-conditioned cultures was harvested and centrifuged at 5000×g for 3 min. The S+Fe-conditioned cultures were resuspended in 30 mL of fresh S+Fe medium for antibiotic susceptibility testing in normal-iron growth conditions ('[Fe] norm ') and S2Fe-conditioned cultures in 30 mL of fresh S2Fe medium for antibiotic susceptibility testing in low-iron growth conditions ('[Fe] low '). To evaluate the effect of 'acute iron limitation' on the antibiotic susceptibility of cells, a third bacterial suspension was prepared by centrifugation of 20 mL of S+Fe-conditioned cultures and subsequent resuspension of the cells in 30 mL of fresh S2Fe medium ('[Fe] D ' conditions). Finally, all solutions of resuspended cells were further diluted with either S+Fe or S2Fe fresh Sauton's medium to an OD 600 of 0.010, corresponding to 1.66×10 6 cfu/mL, as determined by plating serial 10-fold dilutions on Sauton's agar plates.
Antibiotics
The following antibiotics were used: isoniazid, rifampicin, oxacillin sodium salt, streptomycin sulphate, 6-mercaptopurine monohydrate, azithromycin, levofloxacin, 3-nitropropionic acid, sodium salicylate (all from Sigma-Aldrich, USA), D-cycloserine, 4-aminosalicylate and ethambutol dihydrochloride (all from Molekula, UK). The concentration ranges of the antibiotics in the experiments covered the range from subinhibitory concentrations to maximum plasma concentrations of antibiotics during treatment of mycobacteriosis.
Resazurin microplate assay
The resazurin microplate assay was used to determine the antibiotic susceptibility profiles of MAH 104 and was carried out according to published methods. 10 All experiments were conducted in 96-well, sterile, clearbottomed microplates (Greiner Bio-One). Each individual antibiotic experiment used three plates, one for each of the prepared bacterial suspensions. The wells were filled with 140 mL of the bacterial suspension and 20 mL of serial 2-fold antibiotic dilutions (made in S2Fe medium). The experimental controls included blanks for each medium (medium only), positive assay controls (PCTL, bacteria without added antibiotics) and negative assay controls (ACTL, medium with individual antibiotic dilutions, without bacteria). Each concentration of antibiotic (including ACTL) was assayed in triplicate. The plates were incubated for 4 days at 378C, after which resazurin (20 mL, 0.02% w/v) was added to all wells. Growth inhibition profiles were determined by measuring fluorescence Iron affects antibiotic susceptibility of Mycobacterium avium 2905 JAC (BioTek, USA), with excitation at 540 nm and emission at 590 nm, in the bottom read mode. Percentage growth inhibition was defined as 1 2(sample well fluorescence/mean fluorescence of triplicate PCTL wells)×100 and calculated with Gen5 1.10 software (BioTek, USA). The MICs of the antibiotics were determined visually after further incubation at 378C for 4 days in order to allow for complete colour conversion of the wells from blue to pink. The lowest drug concentration that resulted in minimal or no colour conversion was considered to be the MIC. All antibiotic susceptibility experiments were repeated independently at least three times. The statistical significance of differences in the antibiotic susceptibilities between the tested conditions was calculated using a two-tailed Student's t-test.
Results
MICs were determined for 7 out of the 12 antimicrobials. The MICs of oxacillin, ethambutol, 6-mercaptopurine, 4-aminosalicylate and salicylate were not determined, since they were above the tested concentration range.
A significant shift (P,0.05) in the MIC in response to the iron concentration in the medium was detected for four out of seven antimicrobials. The MICs of rifampicin and D-cycloserine were 4-and 2-fold lower, respectively, in both [Fe] (Table 1 ). The observed differences in the MICs of rifampicin, D-cycloserine, isoniazid and azithromycin were also apparent from the growth inhibition profiles (Figure 1c, i, a and h ). The MICs of levofloxacin, streptomycin and 3-nitropropionic acid were not significantly different (P .0.05) between any of the tested iron conditions (Table 1) , but significant differences were observed from the growth inhibition profiles, indicating that the differences in susceptibility were ,2-fold, which was the resolution of the MIC determination procedure. However, these differences were repeatedly observed in all independent replicate experiments, showing that MAH 104 was less susceptible to levofloxacin and streptomycin in [Fe] (Figure 1f and g ). The opposite was observed for 3-nitropropionic acid, but only at concentrations .100 mg/L (Figure 1l) .
Growth inhibition profiles also allowed us to determine the differences in susceptibilities to antibiotics for which MICs could not be determined, since they were higher than the tested concentration range (oxacillin, ethambutol, 6-mercaptopurine, 4-aminosalicylate and salicylate). Oxacillin showed no inhibition, but rather enhanced growth across the whole concentration range in all iron conditions, with a particularly pronounced effect in 
Discussion
Our results show that [Fe] low and [Fe] D conditions increase the resistance of MAH 104 to 6-mercaptopurine and azithromycin, respectively. A minor increase in resistance in [Fe] low was observed also for streptomycin and levofloxacin. Although thiopurines (6-mercaptopurine) are currently not used in the treatment of MAH infection, macrolides (azithromycin and clarithromycin), aminoglycosides (streptomycin and amikacin) and levofloxacinrelated fluoroquinolones (ofloxacin and ciprofloxacin) are among the most frequently prescribed antibiotics used to fight infection with these pathogens. Since mycobacteria are known to experience low-iron conditions in vivo during infection, decreased susceptibility could contribute to lower treatment efficiency with these classes of antibiotics or have a role in the development of drug resistance due to exposure of bacteria to sublethal concentrations of antibiotics. 12 On the contrary, iron limitation caused increased susceptibility of MAH 104 to isoniazid, ethambutol and D-cycloserine, all targeting cell wall synthesis, which suggests that the cell wall is a vulnerable antibiotic target of a low-iron-adapted phenotype. Thus, combining inhibitors of iron acquisition (e.g. 4-aminosalicylate) with antibiotics interfering with cell wall synthesis could potentially lead to improved efficiency of antibiotic treatment of mycobacterial infections.
We have shown that iron limitation can significantly change the susceptibility profile of MAH. However, the actual susceptibility of the in vivo phenotype is most likely dictated by the complex interplay of several host defence mechanisms, which can differ between patients, depending on the immune status and strainspecific interactions with the host. 1, 13 This can, in turn, contribute to the low predictive value of in vitro susceptibility results. Mimicking the host environment in terms of iron availability should be considered for in vitro susceptibility testing of mycobacteria, especially for antibiotics interfering with iron metabolism, such as 4-aminosalicylate.
